Lakefront Biotherapeutics N.V. Profit Margin

The latest profit margin for LKFT is 60.23% as of June 2026. That compares with -103.14% in the prior-year period — up 158.4% year over year. That is above the Healthcare sector average of 9.71%. Investors often review this figure alongside Lakefront Biotherapeutics N.V.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LKFT's profit margin moved from -103.14% to 60.23% — a 158.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lakefront Biotherapeutics N.V.'s valuation or profitability profile.

Against Healthcare companies, LKFT currently prints 60.23% for profit margin, while the sector average sits near 9.71%. That is roughly 520.5% above the sector mean. Large gaps often invite a closer look at Lakefront Biotherapeutics N.V.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Lakefront Biotherapeutics N.V. converts resources into returns. At 60.23%, LKFT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -103.14% in the prior-year period — up 158.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LKFT's profit margin (60.23%), review year-over-year change from -103.14%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.